Mario Ezquerra
Mario Ezquerra
IDIBAPS, Fundacio Clinic de Barcelona
Verified email at
Cited by
Cited by
Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease
A Sánchez‐Danés, Y Richaud‐Patin, I Carballo‐Carbajal, ...
EMBO molecular medicine 4 (5), 380-395, 2012
Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease
Y Compta, MJ Martí, N Ibarretxe‐Bilbao, C Junqué, F Valldeoriola, ...
Movement disorders: official journal of the Movement Disorder Society 24 (15 …, 2009
Significant association between the tau gene A0/A0 genotype and Parkinson's disease
P Pastor, M Ezquerra, E Muñoz, MJ Martí, R Blesa, E Tolosa, R Oliva
Annals of Neurology: Official Journal of the American Neurological …, 2000
LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance
C Gaig, M Ezquerra, MJ Marti, E Muñoz, F Valldeoriola, E Tolosa
Archives of neurology 63 (3), 377-382, 2006
G2019S LRRK2 mutation causing Parkinson’s disease without Lewy bodies
C Gaig, MJ Martí, M Ezquerra, MJ Rey, A Cardozo, E Tolosa
Journal of Neurology, Neurosurgery & Psychiatry 78 (6), 626-628, 2007
Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain
A Lleó, R Blesa, R Queralt, M Ezquerra, JL Molinuevo, J Pena-Casanova, ...
Archives of neurology 59 (11), 1759-1763, 2002
Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease
T Botta‐Orfila, X Morató, Y Compta, JJ Lozano, N Falgas, F Valldeoriola, ...
Journal of neuroscience research 92 (8), 1071-1077, 2014
Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection
R Oliva, E Tolosa, M Ezquerra, JL Molinuevo, F Valldeoriola, J Burguera, ...
Archives of neurology 55 (8), 1122-1124, 1998
Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
R Fernández‐Santiago, I Carballo‐Carbajal, G Castellano, R Torrent, ...
EMBO molecular medicine 7 (12), 1529-1546, 2015
Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies
I Ferrer, I Hernandez, M Boada, A Llorente, MJ Rey, A Cardozo, ...
Acta neuropathologica 106 (5), 419-435, 2003
Further extension of the H1 haplotype associated with progressive supranuclear palsy
P Pastor, M Ezquerra, E Tolosa, E Muñoz, M José Martí, F Valldeoriola, ...
Movement disorders: official journal of the Movement Disorder Society 17 (3 …, 2002
Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans
M Ezquerra, P Pastor, F Valldeoriola, JL Molinuevo, R Blesa, E Tolosa, ...
Neuroscience letters 275 (3), 183-186, 1999
Novel haplotypes in 17q21 are associated with progressive supranuclear palsy
P Pastor, M Ezquerra, JC Perez, S Chakraverty, J Norton, BA Racette, ...
Annals of Neurology: Official Journal of the American Neurological …, 2004
Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease
M Ezquerra, J Campdelacreu, C Gaig, Y Compta, E Muñoz, MJ Martí, ...
Neuroscience letters 448 (1), 20-23, 2008
A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures
M Ezquerra, C Carnero, R Blesa, JL Gelpi, F Ballesta, R Oliva
Neurology 52 (3), 566-566, 1999
Rapidly progressive diffuse Lewy body disease
C Gaig, F Valldeoriola, E Gelpi, M Ezquerra, S Llufriu, M Buongiorno, ...
Movement disorders 26 (7), 1316-1323, 2011
A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances
R Queralt, M Ezquerra, A Lleo, M Castellvi, J Gelpi, I Ferrer, N Acarin, ...
Journal of Neurology, Neurosurgery & Psychiatry 72 (2), 266-269, 2002
The MC1R melanoma risk variant p.R160W is associated with Parkinson disease
G Tell‐Marti, JA Puig‐Butille, M Potrony, C Badenas, M Mila, J Malvehy, ...
Annals of neurology 77 (5), 889-894, 2015
Nonmotor symptoms in LRRK2 G2019S associated Parkinson’s disease
C Gaig, D Vilas, J Infante, M Sierra, I García-Gorostiaga, M Buongiorno, ...
PloS one 9 (10), 2014
Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer’s disease: potential and limitations
M Cosín-Tomás, A Antonell, A Lladó, D Alcolea, J Fortea, M Ezquerra, ...
Molecular neurobiology 54 (7), 5550-5562, 2017
The system can't perform the operation now. Try again later.
Articles 1–20